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ABSTRACT 
 
Triamcinolone acetonide is used in the form of intravitreal injection to treat ocular diseases like uveitis, vasculitis, 
proliferative vitreoretinopathy, macular degeneration etc. But complications have been reported after injection like 
elevated intraocular pressure and cataract. Even though rare, acute retinal necrosis is a risky complication after 
intraocular Triamcinolone acetonide injection, which may cause potential blindness. Here we report a case of acute 
retinal necrosis following intravitreal injection of Triamcinolone acetonide and review the relevant literature. 
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Introduction 
 
 
Triamcinolone Acetonide (TA), a water-insoluble 
corticosteroid is widely used in the field of 
ophthalmology. It can be injected either under tenon’s 
capsule, into the retrobulbar space or directly into the 
vitreous. Machemer used for the first time intravitreal 
injection Triamcinolone Acetonide (IVTA) to prevent 
cellular proliferation after retinal detachment 
surgery[1].Recent studies showed the use of IVTA in 
various ophthalmolgic conditions like uveitis, 
vasculitis, proliferative vitreoretinopathy, macular 
degeneration, clinically significant diabetic macular 
edema (CSDME), pseudophakic/aphakic cystoids 
macular edema etc.
 
These effects are due to the anti-
inflammatory, anti-angiogenic, and anti-permeability 
properties of corticosteroids[2-4].Many complications 
have been reported after IVTA which include elevation 
of intraocular pressure, progression of cataract, Acute 
Retinal Necrosis (ARN), retinal hemorrhage, retinal 
detachment, and endophthalmitis etc. Many case 
reports have shown the local immunue modulatory 
effects after IVTA may cause viral retinitis,  therefore 
close observation is obligatory[5-8].Various studies 
have shown that intraocular corticosteroids might 
reduce the ocular immune response resulting in either a 
primary infection or a latent viral reactivation. On a  
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whole intraocular steroids will cause localised 
immunosuppression. In immunocompromised patients, 
necrotizing retinitis may be usually caused by varicella 
zoster virus (VZV) or herpes simplex virus (HSV) and 
may lead to loss of vision. Hence, timely diagnosis and 
treatment is mandatory to prevent vision loss. But still 
there is a lack of definitive proof of periocular or 
intraocular corticosteroids causing viral retinitis[9-
11].Here we report a case of Acute Retinal Necrosis 
(ARN) following IVTA and review the relevant 
literature. 
 
Case Report 
 
A 65 years old female reported to retina clinic with 
sudden painless loss of vision since 2 days. She 
underwent cataract surgery 3 months back. Intraocular 
lens was not implanted due to posterior capsule rent. 
As she was not improving even with spectacle 
correction, she was referred to retina clinic by general 
ophthalmologist. On examination right eye showed 
immature senile cataract and left eye showed aphakia, 
her ‘Best Corrected Visual Acuity' (BCVA) in right 
eye was 6/18. Right eye fundus was normal, but left 
eye fundus showed macular edema. Fundus fluroscene 
angiography revealed flower petal pattern, Opatientical 
coherence tomography (OCT) showed intra retinal 
cystic spaces with diffuse retinal thickening. A 
diagnosis of aphakic cystoid macular edema was given 
and IVTA was given 0.1 ml /4 mg.4 weeks after 
injection patient vision improved to 6/24 with + 10 
Dsp, secondary Scleral fixated intraocular lens 
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(SFIOL) was planned. Before secondary Intraocular 
lens (IOL) implantation patient came with loss of 
vision, on examination her left eye showed anterior 
chamber flare, fundus was hazy due to mild vitritis and 
wide confluent areas of yellow white necrotic lesions 
with superficial haemorrhages in the periphery was 
noted      (Fig 1 to 5).  
Uveitic and systemic workup was normal. HIV 1 and 2 
results were non reactive. Anterior chamber 
paracentesis for viral PCR was performed. The patient 
was clinically diagnosed as ARN based on the typical 
clinical presentation, but did not have confirmatory 
PCR. Although the causative virus was not detected, 
patient was advised intravitreal anti virals with 
systemic steroids after physician clearance.  
 
Fig 1: Fundus 
image showing 
vitritis with 
confluentareas 
of yellow white 
necrotic retina 
 
Fig 2: Fundus 
image showing 
haemorrhagic 
necrosis of 
retina 
 
 
Fig 3: Fundus 
image after 
treatment 
showing 
resolving 
vitritis with 
occlusive 
vasculopathy 
Fig 4: Fundus 
image showing 
resolving 
haemorrhagic 
necrosed 
retina. 
 
Fig 5: Fundus 
image 1 week 
after surgery, 
Silicone oil 
filled globe 
with attached 
retina 
  
After 3 weeks, patient presented with tractional retinal detachment involving posterior pole one month after intra 
vitreal gangcyclovir. Patient was explained about the prognosis regarding further management, pars plana 
vitrectomy with silicone oil tamponade was done. Patient was advised to continue anti virals for 4 weeks with 
tapering dose of steroids. 
 
Discussion 
 
Very few reports have described the occurrence of 
ARN after injection of corticosteroids. Toh and 
Borthwick reported that corticosteroids reduce the 
eye’s immune response thereby increasing the risk of 
infection or reactivation of dormant organisms. 
Urayama et al (1971) first reported ARN and is most 
commonly seen in young immunocompetent patients, 
but in our case the patient was 65 years old[10-
12].Various clinical manifestations of ARN include 
anterior uveitis, vitritis, necrotizing retinitis, retinal 
vasculitis and optic disc involvement with mild to 
moderate hypermia. Usually the delay in diagnosis of 
ARN is due to the condition being overlooked as 
another uveitic entity and also the lack of use of 
molecular diagnosis. This delay may lead to 
complications resulting in blindness. Poor vision 
usually is due to rhegmatogenous retinal detachment or 
optic neuritis [11-13].Risk factors for ARN include 
young age, history of neurosurgery, periocular trauma, 
compromised immune status, Adminstration of local 
immunosuppressives in the vitreous, and a history of 
viral retinitiA[12-14]. In our case patient was 
administered IVTA. Ankur et al found a half life of 
113 days of 20 mg of IVTA in the vitrectomized eye.
15
 
Whereas Beer et al found a half-life of 18.6 days and 
3.2 days in non vitrectomized and vitrectomized 
patients respectively after administration of standard 4 
mg dose of IVTA. They suggested that IVTA may 
cause the risk of long-lasting local immunosuppression 
and vulnerability to primary infection or reactivation of 
endogenous latent viral retinitis. In our case TA dose 
was only 4 mg and we found that lower dose can also 
cause immunosupression and induce viral retinitis 
[14,15]. 
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 Bacterial endophthalmitis, is also a serious 
complication of IVTA. In our case typical exudates in 
vitreous as well as in anterior chamber and RCS 
thickening were not noted. CMV retinitis also excluded 
by aqueous chamber PCR sample, in CMV retinitis 
lesions were located along the retinal blood vessels and 
sometimes on fovea and disc[14-16]. 
 Few reports have shown that complications 
like immune choroiditis developed as late as 34 years 
after first diagnosis of eye involvement in ARN. Hence 
it is vital to distinguish a purely inflammatory, reactive 
choroiditis and an infective etiology. The choroidal 
involvement might be due to the granulomatous 
infiltration of the choriocapillaris and choroid in ARN 
as also seen in sympathetic ophthalmia and Vogt 
Koyanagi Harada syndrome. Hence, all case of 
unilateral ARN have a risk of developing ARN in other 
eye and also choroiditis[16,17]. 
 Management of ARN should include a 
combination of IVTA and anti virals. Few authors 
however prefer oral corticosteroids. In our case 
systemic steroids were given to reduce the 
inflammation, not IVTA, thinking that IVTA was the 
cause of the ARN[15-17].
 
 Hence IVTA must be judiciously used, as it 
may cause few complications. We recommend 
judicious use of IVTA and monitoring of these injected 
patients as there is a possibility of ARN. 
 
Conclusion 
 
We report a case of  ARN after IVTA in a 65 year old 
female patient. We recommend that physicians should 
be aware of the possibility of necrotizing herpetic 
retinopathy after IVTA, which may lead to blindness. 
The combined findings of severe posterior segment 
inflammation along with peripheral retinal whitening in 
a patient of unknown immune status must alert 
ophthalmologists a likelihood of underlying viral 
infection. Early diagnosis and timely treatment using 
antiviral agents may save these patients from loss of 
visual acuity. 
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